196 related articles for article (PubMed ID: 32237023)
21. The Introduction of Hydrazone, Hydrazide, or Azepane Moieties to the Triterpenoid Core Enhances an Activity Against
Kazakova OB; Medvedeva NI; Smirnova IE; Lopatina TV; Veselovsky AV
Med Chem; 2021; 17(2):134-145. PubMed ID: 31939731
[TBL] [Abstract][Full Text] [Related]
22. Lower cytotoxicity, high stability, and long-term antibacterial activity of a poly(methacrylic acid)/isoniazid/rifampin nanogel against multidrug-resistant intestinal Mycobacterium tuberculosis.
Chen T; Li Q; Guo L; Yu L; Li Z; Guo H; Li H; Zhao M; Chen L; Chen X; Zhong Q; Zhou L; Wu T
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():659-65. PubMed ID: 26478357
[TBL] [Abstract][Full Text] [Related]
23. Isoniazid Monoresistance and Rate of Culture Conversion among Patients in the State of Georgia with Confirmed Tuberculosis, 2009-2014.
Salindri AD; Sales RF; DiMiceli L; Schechter MC; Kempker RR; Magee MJ
Ann Am Thorac Soc; 2018 Mar; 15(3):331-340. PubMed ID: 29131662
[TBL] [Abstract][Full Text] [Related]
24. Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using the Quantamatrix Multiplexed Assay Platform System.
Wang HY; Uh Y; Kim S; Cho E; Lee JS; Lee H
Ann Lab Med; 2018 Nov; 38(6):569-577. PubMed ID: 30027701
[TBL] [Abstract][Full Text] [Related]
25. Transferrin conjugates of antitubercular drug isoniazid: Synthesis and in vitro efficacy.
Sutar YB; Mali JK; Telvekar VN; Rajmani RS; Singh A
Eur J Med Chem; 2019 Dec; 183():111713. PubMed ID: 31557610
[TBL] [Abstract][Full Text] [Related]
26. A Note on Derivatives of Isoniazid, Rifampicin, and Pyrazinamide Showing Activity Against Resistant Mycobacterium tuberculosis.
Nusrath Unissa A; Hanna LE; Swaminathan S
Chem Biol Drug Des; 2016 Apr; 87(4):537-50. PubMed ID: 26613382
[TBL] [Abstract][Full Text] [Related]
27. Development of a three component complex to increase isoniazid efficacy against isoniazid resistant and nonresistant Mycobacterium tuberculosis.
Manning T; Plummer S; Baker T; Wylie G; Clingenpeel AC; Phillips D
Bioorg Med Chem Lett; 2015 Oct; 25(20):4621-7. PubMed ID: 26341133
[TBL] [Abstract][Full Text] [Related]
28. SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.
de Knegt GJ; Bakker-Woudenberg IA; van Soolingen D; Aarnoutse R; Boeree MJ; de Steenwinkel JE
Int J Antimicrob Agents; 2015 Jul; 46(1):66-72. PubMed ID: 25951996
[TBL] [Abstract][Full Text] [Related]
29. Antibacterial Activity of combinatorial treatments composed of transition-metal/antibiotics against Mycobacterium tuberculosis.
Montelongo-Peralta LZ; León-Buitimea A; Palma-Nicolás JP; Gonzalez-Christen J; Morones-Ramírez JR
Sci Rep; 2019 Apr; 9(1):5471. PubMed ID: 30940878
[TBL] [Abstract][Full Text] [Related]
30. Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates.
Islam MM; Tan Y; Hameed HMA; Liu Z; Chhotaray C; Liu Y; Lu Z; Cai X; Tang Y; Gao Y; Surineni G; Li X; Tan S; Guo L; Cai X; Yew WW; Liu J; Zhong N; Zhang T
Clin Microbiol Infect; 2019 Aug; 25(8):1041.e1-1041.e7. PubMed ID: 30583053
[TBL] [Abstract][Full Text] [Related]
31. Isoniazid-resistant tuberculosis in Iran: A systematic review.
Javad Nasiri M; Chirani AS; Amin M; Halabian R; Imani Fooladi AA
Tuberculosis (Edinb); 2016 May; 98():104-9. PubMed ID: 27156625
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro antitubercular activity of pyridine analouges against the resistant Mycobacterium tuberculosis.
Patel H; Chaudhari K; Jain P; Surana S
Bioorg Chem; 2020 Sep; 102():104099. PubMed ID: 32711084
[TBL] [Abstract][Full Text] [Related]
33. The occurrence and frequency of genomic mutations that mediate Isoniazid and Rifampicin resistance in
Kumwenda GP; Chipungu G; Sloan DJ; Kaimila Y; Chiumya K; Pangani H
Malawi Med J; 2018 Mar; 30(1):1-5. PubMed ID: 29868151
[TBL] [Abstract][Full Text] [Related]
34. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
[TBL] [Abstract][Full Text] [Related]
35. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
36. Study of mechanism of interaction of truncated isoniazid-nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach.
Jena L; Deshmukh S; Waghmare P; Kumar S; Harinath BC
Int J Mycobacteriol; 2015 Dec; 4(4):276-83. PubMed ID: 26964808
[TBL] [Abstract][Full Text] [Related]
37. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis.
Unissa AN; Subbian S; Hanna LE; Selvakumar N
Infect Genet Evol; 2016 Nov; 45():474-492. PubMed ID: 27612406
[TBL] [Abstract][Full Text] [Related]
38. Combinatory activity of linezolid and levofloxacin with antituberculosis drugs in Mycobacterium tuberculosis.
Santos NCS; Scodro RBL; de Almeida AL; Baldin VP; Nakamura de Vasconcelos SS; Siqueira VLD; Caleffi-Ferracioli KR; Campanerut-Sá PAZ; Cardoso RF
Tuberculosis (Edinb); 2018 Jul; 111():41-44. PubMed ID: 30029913
[TBL] [Abstract][Full Text] [Related]
39. Isolation and characterization of nontuberculous mycobacteria from patients with pulmonary tuberculosis in Ghana.
Otchere ID; Asante-Poku A; Osei-Wusu S; Aboagye SY; Yeboah-Manu D
Int J Mycobacteriol; 2017; 6(1):70-75. PubMed ID: 28317808
[TBL] [Abstract][Full Text] [Related]
40. MDR-TB Antibody Response (Western Blot) to Fractions of Isoniazid and Rifampicin Resistant Antigens of Mycobacterium tuberculosis.
Hadizadeh Tasbiti A; Yari S; Ghanei M; Shokrgozar MA; Bahrmand A
Curr Microbiol; 2015 Dec; 71(6):638-42. PubMed ID: 26316231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
